Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO |
November 21, 2019 | November 2019 Bond Updates |
TARRYTOWN, N.Y., Nov. 21, 2019 /PRNewswire/ -- Araim Pharmaceuticals, Inc. is pleased to announce the appointment of Ferdinand "Ferry" Breedveld, MD, PhD, the Chairman of the Board at Araim, as the organization's acting Chief Executive Officer. Dr. Breedveld brings more than 40 years of... |
View more at: https://www.prnewswire.com:443/news-releases/araim-pharmaceuticals-selects-ferry-breedveld-as-acting-ceo-300962606.html |
Related News |
|